Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
Kunio NakamuraMarisa P McGinleyStephen E JonesMark J LoweJeffrey A CohenPaul M RuggieriDaniel OntanedaPublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2022)
No detrimental effects were observed between GBCA exposure and self-reported disability and standardized objective measures of physical and cognitive performance. While several weak associations were found, they indicated benefit on these measures.